HB 362 & HB 588 - Controlled Substances by Fawcett, William & Meeks, April
Georgia State University Law Review
Volume 33
Issue 1 Fall 2016 Article 7
11-8-2016
HB 362 & HB 588 - Controlled Substances
William Fawcett
Georgia State University College of Law, wfawcett1@student.gsu.edu
April Meeks
Georgia State University College of Law, aprilmeeks13@gmail.com
Follow this and additional works at: https://readingroom.law.gsu.edu/gsulr
Part of the Legislation Commons
This Peach Sheet is brought to you for free and open access by the Publications at Reading Room. It has been accepted for inclusion in Georgia State
University Law Review by an authorized editor of Reading Room. For more information, please contact mbutler@gsu.edu.
Recommended Citation
William Fawcett & April Meeks, HB 362 & HB 588 - Controlled Substances, 33 Ga. St. U. L. Rev. 97 (2016).
Available at: https://readingroom.law.gsu.edu/gsulr/vol33/iss1/7
  
97
CRIMES AND OFFENSES 
Controlled Substances: Amend Article 2 of Chapter 13 of Title 16 
of the Official Code of Georgia Annotated, Relating to Regulation 
of Controlled Substances, so as to Change Provisions Relating to 
Possession of Substances Containing Ephedrine, Pseudoephedrine, 
and Phenylpropanolamine and Restrictions on Sales of Products 
Containing Pseudoephedrine; Provide for Real-Time Tracking of 
Sales of Products Containing Ephedrine, Pseudoephedrine; 
Provide for Definitions; Revise Provisions Relating to Exceptions; 
Provide for Related Matters; Repeal Conflicting Laws; and for 
Other Purposes 
CODE SECTIONS: O.C.G.A. § 16-13-30.3 
BILL NUMBER: HB 362; HB 588 
ACT NUMBER: 392 
GEORGIA LAWS: 2016 Ga Laws 273 
SUMMARY: The Act mandates the installation of 
real-time electronic tracking systems in 
all pharmacies that sell products 
containing ephedrine and 
pseudoephedrine, which are ingredients 
used in the manufacture of 
methamphetamine. When customers 
attempt to purchase more than the 
maximum amount of these products, 
the tracking system blocks the sale by 
issuing a stop sale alert. 
EFFECTIVE DATE: July 1, 2016 
History 
Methamphetamine, also known as “meth” or “crystal meth,” is one 
of the most addictive controlled substances.1 Methamphetamine 
                                                                                                                 
 1. About Methamphetamine, GA. METH PROJECT, http://georgiamethproject.org/Meth-
Info/index.php (last visited Sep. 3, 2016). 
1
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dramatically affects the pleasure centers of the brain, and eventually 
leaves user incapable of deriving pleasure from anything other than 
the drug, driving abusers further into addiction.2 Other side effects of 
the drug include extreme violence, anxiety, insomnia, paranoia, 
visual and auditory hallucinations, and delusions.3 
While most methamphetamine is manufactured in “superlabs” 
across the United States and Mexico, the drug is also easily created in 
small, makeshift laboratories using inexpensive over-the-counter 
ingredients, such as pseudoephedrine and ephedrine.4 
Pseudoephedrine and ephedrine are commonly found in cold 
medicines.5 In an effort to eliminate these smaller labs, thirty-two 
states have armed their pharmacies, supermarkets, and law 
enforcement agencies with advanced real-time electronic logging 
systems to track the purchase of products containing 
pseudoephedrine and ephedrine.6 
For the past seven years, the Georgia House of Representatives has 
attempted to pass legislation mandating pharmacies and supermarkets 
to use electronic tracking systems.7 Though CVS and other big-box 
pharmacies in Georgia already use electronic tracking systems, the 
high cost of implementation prevents many supermarkets and 
independent pharmacies from using these systems.8 Consequently, 
many supermarkets and pharmacies in Georgia still use “paper logs 
and handwritten entries” to record the purchase of products 
containing pseudoephedrine and ephedrine.9 
                                                                                                                 
 2. What Are the Long-Term Effects of Methamphetamine Abuse?, NAT’L INST. ON DRUG ABUSE, 
https://www.drugabuse.gov/publications/research-reports/methamphetamine/what-are-long-term-
effects-methamphetamine-abuse (last visited Sep. 3, 2016). 
 3. Id. A common delusion of abusers is the sensation of insects crawling under the skin. Id. 
 4. DrugFacts: Methamphetamine, NAT’L INST. ON DRUG ABUSE, https://www.drugabuse.gov/ 
publications/drugfacts/methamphetamine (last updated Jan. 2014) [hereinafter DrugFacts]; What’s in 
Meth, THE METH PROJECT, http://www.methproject.org/answers/what-is-meth.html#Whats-in-Meth 
(last visited Sep. 3, 2016) (listing other common ingredients including acetone, lithium, toluene, 
hydrochloric acid, red phosphorus, sodium hydroxide, sulfuric acid, and anhydrous ammonia). 
 5. DrugFacts, supra note 4. 
 6. Kristina Torres, Georgia House Votes to Enforce Limits for Medicine Used to Make Meth, 
ATLANTA J.-CONST. (Feb. 16, 2016, 1:56 PM), http://www.ajc.com/news/news/state-regional-govt-
politics/georgia-house-votes-to-enforce-limits-for-medicine/nqQ67/; NPLEx States, APPRISS, 
http://www.appriss.com/nplex.html (last visited Sep. 3, 2016). 
 7. Telephone Interview with Rep. Valerie Clark (R-101st) (July 8, 2016) [hereinafter Clark 
Interview]. 
 8. Id. 
 9. Laura Diaz, Ga. Bill Would Enforce Limits on Purchases of Medicine Used in Meth, ATLANTA 
2
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During Georgia’s 2016 legislative session, the Georgia House 
made its eighth attempt to pass a bill requiring real-time tracking of 
products containing pseudoephedrine and ephedrine. 10 The bill, 
House Bill (HB) 588—later changed to HB 362—offers the 
electronic tracking system free of charge to supermarkets, 
pharmacies, and law enforcement agencies across Georgia.11 
Bill Tracking of HB 588 
Consideration by the House 
Representatives Valerie Clark (R-101st), Sharon Cooper (R-43rd), 
Bruce Broadrick (R-4th), E. Culver “Rusty” Kidd (I-145th), Ed 
Rynders (R-152nd), and Barbara Sims (R-123rd) sponsored HB 
588.12 The House read the bill for the first time on March 11, 2015 
and recommitted it to the Health and Human Services committee.13 
The House Committee on Health and Human Services offered a 
substitute to the bill, which the House read on January 27, 2016.14 
The Committee substitute reorganized much of the introduced 
bill’s substantive inserts.15 For example, the substitute removed the 
phrase “retail distributor” and the word “norpsuedoephedrine.”16 The 
substitute also significantly changed Section (c) by removing 
language that forced retailers to sell products containing only 
pseudoephedrine from behind a counter or similar barrier.17 
Between March 13, 2015 and January 27, 2016, the Committee 
met separately with small pharmacies, grocery store pharmacies, the 
GBI, Director Rick Allen from the Georgia Drugs and Narcotics 
                                                                                                                 
J.-CONST.: MYAJC (Jan. 29, 2016, 4:28 PM), http://www.myajc.com/news/news/state-regional-govt-
politics/ga-bill-would-enforce-limits-on-purchases-of-medic/nqFqh/. 
 10. Torres, supra note 6. 
 11. Diaz, supra note 9. 
 12. Georgia General Assembly, HB 588, Bill Tracking, 
http://www.legis.ga.gov/Legislation/en-US/display/20152016/HB/588. 
 13. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016. The House read the bill 
again on March 13, 2015. Id. 
 14. Id. 
 15. Compare HB 588, as introduced, 2015 Ga. Gen. Assemb., with HB 588 (6327S), 2016 Ga. Gen. 
Assemb. 
 16. Id. 
 17. HB 588 (6327S), § 1, p. 3, ll. 63–65, 2016 Ga. Gen. Assemb. 
3
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Agency, and Attorney General Sam Olens.18 They all suggested 
allowing the information to go the GBI first, instead of the national 
database, which would allow these regulations “to be better 
enforced.”19 Representative Clark believes Mr. Clark’s and Mr. 
Olens’ changes “made a better bill.”20 
The Rules Committee withdrew the bill and recommitted it to the 
Committee on Health and Human Services on February 4, 2016.21 
The new substitute kept all of the changes and phrasing of the 
previous substitute, except for a change in subsection (a)(4)(B).22 
This section specified retailers would not have to pay transaction fees 
for tracking software.23 
The House Committee on Health and Human Services favorably 
reported the bill on February 10, 2016.24 The House read the bill for 
the third time on February 16, 2016.25 It passed the same day by a 
vote of 151 to 19.26 
Consideration by the Senate 
Senator Renee Unterman (R-45th) sponsored HB 588 in the 
Senate.27 The Senate first read HB 588 on February 17, 2016, and 
assigned it to the Senate Health and Human Services Committee.28 
The Senate Health and Human Services Committee favorably 
reported the bill on March 7, 2016.29 The Senate read the bill for the 
second time on March 8, 2016.30 
                                                                                                                 
 18. Clark Interview, at 7:40–9:18 
 19. Id. 
 20. Id. 
 21. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016. 
 22. Compare HB 588 (6327S), § 1, p. 2, l. 41, 2016 Ga. Gen. Assemb., with HB (6465S), § 1, p. 2, l. 
41, 2016 Ga. Gen. Assemb. 
 23. HB 588 (6465S), § 1, p. 2, l. 4l, 2016 Ga. Gen. Assemb. 
 24. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016. 
 25. Id. 
 26. Georgia House of Representatives Voting Record, HB 588, Vote #542 (Feb. 16, 2016). 
 27. Georgia General Assembly, HB 588, Bill Tracking, 
http://www.legis.ga.gov/legislation/en-US/Display/20152016/HB/588. 
 28. State of Georgia Final Composite Status Sheet, HB 588, May 5, 2016. 
 29. Id. 
 30. Id. 
4
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On March 15, 2016, the Senate read HB 588 for the third time.31 
After the third reading, Senators Unterman (R-45th), Rick Jeffares 
(R-17th), Bill Jackson (R-24th), and Chuck Hufstetler (R-52nd) 
proposed a floor amendment to the bill.32 The amendment 
recommended revising paragraph (e.1)(1) and adding subparagraph 
(e.1)(1)(B) to Code section 43-34-103.33 The recommended revisions 
would allow physician assistants to write prescription drug orders for 
hydrocodone compounds.34 Physician assistants had lost the power to 
prescribe such drugs in 2014 when the Drug Enforcement Agency 
(DEA) moved several Schedule III drugs, such as hydrocodone based 
compounds, up to Schedule II.35 
The Senate adopted the amendment by a vote of 22 to 3.36 It then 
passed HB 588 as amended on March 15, 2016, by a vote of 39 to 
1.37 The bill was then set aside to be resolved in a conference 
committee with the House.38 
Reconsideration of HB 588 by the House and its Transformation 
into HB 362 
The Chairwoman of Health and Human Services, Representative 
Cooper, and other members of the House took issue with the Senate’s 
amendments to HB 588, granting physician assistants the ability to 
prescribe Schedule II drugs.39 Representative Cooper and others 
expressed serious concern that the amendment would ease access to 
highly addictive drugs, thereby furthering opioid abuse in Georgia.40 
Opponents of the Senate amendments fears are bolstered by statistics 
showing that prescription drug abuse in Georgia has declined since 
                                                                                                                 
 31. Id. 
 32. Video Recording of Senate Proceedings, Mar. 15, 2016 at 5 min., 5 sec. (remarks by Sen. 
Jeffares (R-17th)), http://www.gpb.org/lawmakers/2016/day-37 [hereinafter Senate Video]. 
 33. HB 588 (SFA), p. 1, l. 8, 2016 Ga. Gen. Assemb. 
 34. Senate Video, supra note 32, at 5 min., 5 sec. (remarks by Sen. Jeffares (R-17th)). 
 35. Diane Wagner, Sen. Chuck Hufstetler at Work on Health Bills for Action in January, ROME 
NEWS-TRIB. (Nov. 30, 2015, 9:00 AM), http://www.northwestgeorgianews.com/rome/news/local/sen-
chuck-hufstetler-at-work-on-health-bills-for-action/article_f4c37316-973f-11e5-a7e7-
8b72936e0914.html. 
 36. Senate Video, supra note 32, at 5 min., 53 sec. (remarks by LG Casey Cagle). 
 37. Georgia Senate Voting Record, HB 588, Vote #604 (Mar. 15, 2016). 
 38. Senate Video, supra note 32, at 5 min., 25 sec. (remarks by Sen. Unterman (R-45th)). 
 39. Clark Interview, supra note 7, at 4 min., 10 sec. 
 40. Id. 
5
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the DEA moved hydrocodone compounds and other Schedule II 
drugs above the prescription authority of physician assistants.41 
Even though the House and Senate remained in agreement about 
the importance of HB 588’s initial purpose—installing electronic 
tracking systems in drug stores to track the sale of 
pseudoephedrine—the House refused to pass the bill as amended.42 
As a solution, the House and Senate decided to proceed without the 
amendment and added HB 588 to HB 362.43 Both the House and the 
Senate passed HB 362 on March 24, 2016.44 
The Act (HB 362) 
The Act creates Code section 16-13-30.3 of Article 2 of Chapter 
13 of Title 16.45 This section defines several different terms related to 
the electronic tracking system, outlines the requirements of the 
tracking system, and sets out the punishment for anyone in violation 
of the code section.46 Code section 16-13-30.3(a)(1) defines 
ephedrine and pseudoephedrine as “any drug product containing 
ephedrine or pseudoephedrine, or any other of their salts, isomers, or 
salts of isomers, alone or in a mixture.”47 
Real-Time Tracking System 
Code section 16-13-30.3 mandates all pharmacies to install 
electronic logging systems that operate in real time and generate stop 
sale alerts to notify pharmacists when someone has purchased more 
than the maximum amount of ephedrine or pseudoephedrine.48 To 
ensure pharmacist safety, however, every system must also be 
equipped with a safety override. The safety override function allows 
pharmacists to complete a sale in violation of Code section 
                                                                                                                 
 41. Id. at 5 min., 5 sec. 
 42. Id. 
 43. Id. 
 44. State of Georgia Final Composite Status Sheet, HB 362, May 5, 2016. 
 45. O.C.G.A. § 16-13-30.3 (Supp. 2016). 
 46. Id. 
 47. O.C.G.A. § 16-13-30.3(a)(1). 
 48. O.C.G.A. § 16-13-30.3(a)(4), (c)(4)(A). 
6
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16-13-30.3 when he or she is in reasonable fear of imminent bodily 
harm as a consequence of not completing the sale.49 
When an individual buys any product containing ephedrine or 
pseudoephedrine for the first time, he or she is required to give the 
pharmacist his or her full name, address, and present a government 
issued identification card.50 The pharmacist must input this 
information into the tracking system, along with a description of the 
nonprescription ephedrine or pseudoephedrine product, including the 
number of grams of ephedrine or pseudoephedrine contained in the 
product, and the time and date of purchase.51 The pharmacy must 
keep records of all sales for a period of two years from the date of 
each transaction.52 The records are accessible to Georgia law 
enforcement agencies through an online portal maintained by the 
Georgia Bureau of Investigation.53 
Every logging system must be approved by the Georgia Bureau of 
Investigation and must be accessible to the state, pharmacies, and law 
enforcement completely free of charge.54 
While such systems must have real-time interstate 
communicability with similar systems in other states, the records 
maintained by a pharmacy shall not be disclosed to anyone other than 
Georgia law enforcement agencies.55 
Criminalizing Possession of Products Containing Ephedrine or 
Pseudoephedrine 
Code section 16-13-30.3 (b)(1) states that any person who possess 
more than 300 pills, tablets, gelcaps, or capsules that contain 
ephedrine or pseudoephedrine or more than nine grams of ephedrine 
shall be guilty of a felony punishable by imprisonment for not less 
than one year but no more than ten.56 The same punishment applies 
to someone who possesses any amount of ephedrine- or 
                                                                                                                 
 49. O.C.G.A. § 16-13-30.3(a)(4). 
 50. O.C.G.A. § 16-13-30.3(a)(5), (c)(3). 
 51. O.C.G.A. § 16-13-30.3(a)(5), (c)(3). 
 52. O.C.G.A. § 16-13-30.3(c)(3). 
 53. O.C.G.A. § 16-13-30.3(c)(4)(D). 
 54. O.C.G.A. § 16-13-30.3(a)(4). 
 55. O.C.G.A. § 16-13-30.3(c)(3). 
 56. O.C.G.A. § 16-13-30.3(b)(1), (3). 
7
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pseudoephedrine-based products with the intent to manufacture 
amphetamine or methamphetamine, or anyone who possesses, with 
the intent to distribute, any product containing any amounts of 
ephedrine or pseudoephedrine that have been crushed, powdered, 
liquefied, or altered in any other manner.57 A person may legally 
purchase or sell 3.6 grams of ephedrine or pseudoephedrine per 
day.58 However, this amount cannot reach more than nine grams per 
thirty-day period.59 
Products Containing Pure Ephedrine or Pseudoephedrine 
Code section 16-13-30.3(c)(1) states that any products whose sole 
active ingredient is pseudoephedrine must be sold in blister 
packaging.60 Any nonprescription products whose sole active 
ingredient is ephedrine or pseudoephedrine must comply with Code 
section 16-13-29.2.61 
Liability of Pharmacies 
Starting January 1, 2017, pharmacies that do not use a real time 
tracking system will not be permitted to sell products containing 
ephedrine or pseudoephedrine.62 If, for some reason, the system 
malfunctions, the pharmacy must record any sales in either a written 
or an electronic log.63 Pharmacies are also prohibited from selling 
any non-prescription product that contains more than 3.6 grams of 
ephedrine or pseudoephedrine per day dosage or more than 9 grams 
per a 30 day period dosage to an individual.64 And as noted above, if 
the sole active ingredient is pseudoephedrine it must be sold in blister 
packaging.65 Any pharmacy or pharmacist who fails to comply with 
any of the above requirements or fails to record sales shall be guilty 
                                                                                                                 
 57. O.C.G.A. § 16-13-30.3(b)(2), (e). 
 58. O.C.G.A. § 16-13-30.3(c)(2). 
 59. Id. 
 60. O.C.G.A. § 16-13-30.3(c)(1). 
 61. Id. 
 62. O.C.G.A. § 16-13-30.3(c)(4). 
 63. O.C.G.A. § 16-13-30.3(c)(4)(B). 
 64. O.C.G.A. § 16-13-30.3(c)(1), (2). 
 65. O.C.G.A. § 16-13-30.3(c)(1). 
8
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of a misdemeanor punishable of a fine no more than $500 upon first 
conviction and upon second conviction no more than six months 
imprisonment, a $1000 fine, or both.66 
If a pharmacy buys products containing ephedrine or 
pseudoephedrine from anyone other than a manufacturer or 
distributor licensed by the State Board of Pharmacy, it shall be guilty 
of a misdemeanor and upon the second conviction shall be guilty of a 
high and aggravated misdemeanor.67 
It shall be a defense to any of the above criminal allegations, if all 
employees of the pharmacy completed training that complied with 
the standards established by Georgia Meth Watch as of June 30, 
2016, and the pharmacy actually complied with the procedures 
developed by Georgia Meth Watch.68 Except in cases of negligence, 
wantonness, recklessness, or deliberate misconduct, pharmacies 
using the real-time tracking system cannot be held civilly liable for 
any act or omission in carrying out the duties required by Code 
section 16-13-30.3.69 Pharmacies are also immune from liability to 
any third party unless the pharmacy violates Code section 
16-13-30.3.70 
Analysis 
Comparison With Other States 
By adopting HB 362, Georgia joins the several other states that 
have passed legislation requiring drug tracking programs.71 In 
particular, Georgia’s neighboring states have adopted such legislation 
because the drug tracking system leads investigators “to meth labs 
[they] otherwise wouldn’t know about.”72 Mississippi is the only 
other state in the southeast that has not implemented a requirement 
                                                                                                                 
 66. O.C.G.A. § 16-13-30.3(c)(7)(A). 
 67. O.C.G.A. § 16-13-30.3(c)(7)(B). 
 68. O.C.G.A. § 16-13-30.3(c)(7)(C). 
 69. O.C.G.A. § 16-13-30.3(c)(4)(C). 
 70. Id. 
 71. Torres, supra note 6; see NPLEx States, APPRISS (2015), http://www.appriss.com/nplex.html 
(last visited Sep. 3, 2016). 
 72. Press Release, N.C. Dep’t of Just., Technology leads to record number of meth lab busts in NC 
(Jan. 19. 2014), http://www.ncdoj.gov/News-and-Alerts/News-Releases-and-Advisories/Press-Releases/ 
Technology-leads-to-record-number-of-meth-lab-bust.aspx. 
9
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for pharmacies to join a real-time electronic logging system.73 With 
the passage of HB 588, Georgia has joined the majority of its 
neighbors in taking steps to curb meth production. 
Intended Consequences 
At its core, this law aims to further restrict methamphetamine 
makers’ ability to obtain the necessary supplies.74 Yet, the law also 
allows consumers to more easily obtain allergy medications by taking 
them to the shelves instead of placing them behind pharmacy 
counters.75 To combat the concern that this would create an easier 
avenue for methamphetamine producers to gather the requisite 
ingredients, the Act requires all pharmacies to have a real-time 
electronic logging system.76 
First, this Act prevents methamphetamine producers from taking 
advantage of small pharmacies by going to multiple pharmacies in a 
single day and purchasing more than the maximum amount of the 
drugs.77 Without a real-time system to inform a pharmacy that a 
purchaser recently bought the same drug somewhere else, purchasers 
were able to get around the legal limit.78 This Act prevents that from 
occurring because of its real-time logging component.79 The real-
time technology allows pharmacies to track the amount of a drug 
purchased by an individual at any pharmacy in the state.80 
Mild Opposition 
The Act initially had some opposition.81 The most notable concern 
dealt with the vesting of power in physician assistant’s to prescribe 
                                                                                                                 
 73. See NPLEx, supra note 6. 
 74. Torres, Kristina, Georgia Senate Backs Bill Limiting Medicine Used to Make Meth, ATLANTA J.-
CONST. (Mar. 15, 2016 1:41 PM), http://www.ajc.com/news/news/state-regional-govt-politics/georgia-
senate-backs-bill-limiting-medicine-used-t/nqk4J/. 
 75. Diaz, supra note 9. 
 76. Id. 
 77. FINAL REPORT OF THE SENATE STUDY COMMITTEE ON THE CREATION OF A GEORGIA 
METHCHECK DATABASE, S. 150, Reg. Sess., at 8 (2009). 
 78. Id. at 6. 
 79. O.C.G.A. § 16-13-30.3(c)(4)(A) (Supp. 2016). 
 80. See Diaz, supra note 9. 
 81. Georgia House Voting Record, HB 588, Vote #542 (Feb. 16, 2016) (passing the House by a vote 
of 151-19); Georgia Senate Voting Record, HB 588, Vote #604 (Mar. 15, 2016) (passing the Senate by a 
10
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painkillers.82 However, support from the GBI, attorney general, and 
director of the Georgia Drugs and Narcotics Agency in favor of the 
tracking implementation apparently outweighed the detractors’ 
original concerns.83 The bill also directly addressed any potential 
opposition—although none materialized—from pharmacies, who 
could have been concerned about liability in situations out of their 
control, such as system outages, by carving out protections for 
pharmacies that attempt to comply with the system.84 Further, the 
pharmaceutical companies that backed the Act offered to pay for the 
logging system.85 Thus, pharmacies that might fear increased costs 
will incur no extra expense from implementation of the real-time 
monitoring system.86 
This Act does not hurt pharmacies, because it does not require 
them to pay for the monitoring expense.87 At the same time, this Act 
will make it more difficult for meth producers to acquire the 
necessary supplies, because it requires every pharmacy to utilize the 
real-time tracking system.88 Other states that have adopted the system 
have seen a substantial increase in the amount of blocked sales of 
pseudoephedrine.89 For example, Arkansas began using the tracking 
system in 2015, and within the first year blocked 3,873 sales of 
banned ingredients; from January through June of 2016, Arkansas 
blocked 3,722 sales.90 North Carolina found the system helped in 
setting a record for meth lab busts.91 Finally, the Act makes it easier 
for consumers to obtain necessary allergy medications by moving 
these medications from behind the counter back onto the shelves.92 
William Fawcett & April Meeks 
                                                                                                                 
vote of 39-1); Clark Interview supra note 7, at 9:15. 
 82. Id. 
 83. Id. 
 84. O.C.G.A. § 16-13-30.3(c)(4) (Supp. 2016). 
 85. Torres, supra note 74. 
 86. Id. 
 87. Id. 
 88. O.C.G.A. § 16-13-30.3(a)(4), (c)(4)(A) (Supp. 2016). 
 89. See generally Appriss tables, infra note 91. 
 90. Compare Appriss 2015 year end table (http://www.appriss.com/actionable/NPLEx/ 
EOY2015.htm), with Apriss 2016 2Q table (http://www.appriss.com/actionable/NPLEx/ 
2Q2016Stats.htm). 
 91. N.C. Dep’t Just., supra note 72. 
 92. See Diaz, supra note 9. 
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